摘要 |
<p>The present invention relates to compounds having a structure according to Formula (I) wherein n, m, z, R, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, R<SUB>5</SUB>, R<SUB>6</SUB>, A, E, X, Y, a and b are as defined above; or an optical isomer, diastereomer or enantiomer thereof; a pharmaceutically acceptable salt, hydrate, or prodrug thereof.</p> |
申请人 |
JANSSEN PHARMACEUTICA, N.V.;GRANT, EUGENE, B., III;MACIELAG, MARK, J.;PAGET, STEVEN, DAVID;WEIDNER-WELLS, MICHELE ANN;XU, XIAOQING;XU, XIODONG |
发明人 |
GRANT, EUGENE, B., III;MACIELAG, MARK, J.;PAGET, STEVEN, DAVID;WEIDNER-WELLS, MICHELE ANN;XU, XIAOQING;XU, XIODONG |